| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.098 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.094 | 0.1 |